Funding for this research was provided by:
Academy of Finland (331671, 312076, 288509, 128650, 308248, 131449, 218068, 312062, 285380)
Jane ja Aatos Erkon Säätiö
Received: 15 July 2020
Accepted: 6 November 2020
First Online: 14 December 2020
: A.P. is a member of the Pfizer Genetics Scientific Advisory Panel. H.J. has a co-appointment at Orion Pharma, has received fees from Neutron Therapeutics, and owns stocks of Orion Pharma and Sartar Therapeutics. The remaining authors declare no competing interests.